Grantham, Mayo, Van Otterloo & Co (GMO)’s Nice NICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.6M Sell
193,368
-17,739
-8% -$1.72M 0.04% 200
2026
Q1
$23.3M Buy
211,107
+12,971
+7% +$1.48M 0.06% 170
2025
Q4
$22.4M Buy
198,136
+77,679
+64% +$9.38M 0.06% 158
2025
Q3
$17.4M Buy
120,457
+24,070
+25% +$3.61M 0.05% 185
2025
Q2
$16.3M Sell
96,387
-27,625
-22% -$4.45M 0.05% 196
2025
Q1
$19.1M Buy
124,012
+51,036
+70% +$8.16M 0.06% 192
2024
Q4
$12.4M Buy
72,976
+5,230
+8% +$932K 0.04% 237
2024
Q3
$11.8M Buy
+67,746
New +$11.6M 0.04% 254
2019
Q3
Sell
-17,200
Closed -$2.36M 768
2019
Q2
$2.36M Buy
+17,200
New +$2.32M 0.02% 421

Other funds holding NICE

Grantham, Mayo, Van Otterloo & Co (GMO)'s NICE Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Nice (NICE) stake by 8.4% in Q2 2026, selling an estimated $1.72M and leaving 193,368 shares worth $17.6M. The position accounts for 0.04% of the portfolio, ranked #200.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NICE in Q2 2019 and has held it in 9 quarters since. The position peaked at $23.3M in Q1 2026. 320 funds tracked by Wall St. Rank hold NICE as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 193,368 shares of Nice worth $17.6M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 17,739 Nice shares in Q2 2026, an estimated $1.72M.
  • Nice made up 0.04% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #200 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nice in Q2 2019 and has held it in 9 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nice position peaked at $23.3M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Nice as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.